Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma ; volume:41 ; number:1 ; day:22 ; month:10 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of experimental & clinical cancer research ; 41, Heft 1 (22.10.2022), 1-21, 12.2022
- Urheber
-
Li, Meng
Han, Yujie
Wang, Chaochen
Kang, Wenfeng
Jiang, Wenyan
Zhang, Lei
Tang, Yujie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-022-02506-y
- URN
-
urn:nbn:de:101:1-2023010621002866019598
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Meng
- Han, Yujie
- Wang, Chaochen
- Kang, Wenfeng
- Jiang, Wenyan
- Zhang, Lei
- Tang, Yujie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.
Handling Transitive Dependencies
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.
Handling Transitive Dependencies
Dissecting the genomic complexity underlying medulloblastoma
HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma
Dissecting super-enhancer hierarchy based on chromatin interactions
Dissecting the OCT4-governed enhancer landscape in mouse embryonic stem cells
Dissecting the role of lymphoid enhancer factor 1 (LEF1) in acute myeloid leukemia
Medulloblastoma cerebelli
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level
Expression of somatostatin receptor subtype 2 (sst2) is a prognostic marker and therapeutic target in high risk medulloblastoma
Raman spectroscopy for medulloblastoma
A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma
Exclusion of Dependencies.